Annual report [Section 13 and 15(d), not S-K Item 405]

Conoslidated Statements of Cash Flows

v3.26.1
Conoslidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss for the year $ (8,261) $ (4,374)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 20 26
Changes in fair value related to warrants to lenders and investors (8)
Inventory write-downs 268 101
Financial expenses (income) 198 (24)
Share-based compensation 309 337
Issuance costs of ELOC agreement 750
Changes in operating assets and liabilities:    
Trade receivables 559 (952)
Net change in operating lease assets and liabilities (44) 26
Inventories (293) (11)
Prepaid expenses and other current assets (18) (143)
Trade payables (166) (787)
Deferred revenues (95) (122)
Other current liabilities (747) (580)
Other long-term liabilities (171) (38)
Net cash used in operating activities (7,691) (6,549)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Short term deposit 1 198
Purchase of property and equipment (9) (1)
Net cash provided by investing activities (8) 197
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of options 32
Proceeds from issuance common stock - at the market offering (ATM) 2,637 2,063
Offering cost from issuance of common stock - at the market offering (ATM) (262) (125)
Proceeds from warrant inducement agreement 1,580 5,248
Underwriting commissions and other offering costs (193) (668)
Proceeds from Exercise of Pre funded warrants into common stock
Proceeds from issuance of common stocks and pre funded warrants – September PIPE 850
Offering cost from issuance of common stocks and pre funded warrants – September PIPE (60)
Proceeds from issuance of common stocks and warrants – July PIPE 1,000
Offering cost from issuance of common stock and warrants – July PIPE (161)
Proceeds from issuance of common stocks and warrants – December Follow on 5,000
Offering cost from issuance of common stock and warrants – December Follow on (705)
Proceeds from issuance common stock – ELOC issuance 56  
Credit line, net (295) 774
Proceeds from short term loans 750
Repayment of short term loans (400)
Early repayment of long-term loan (4,038)
Repayment of long-term loan (193)
Net cash provided by financing activities 9,797 3,093
Effect of exchange rate changes on cash and cash equivalents and restricted cash (3) 11
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 2,095 (3,248)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF YEAR 2,267 5,515
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF YEAR 4,362 2,267
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH:    
Cash and cash equivalents 4,057 1,967
Restricted cash equivalents, current 305 300
Total cash, cash equivalents and restricted cash 4,362 2,267
SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for interest 348 624
SUPPLEMENTARY INFORMATION ON INVESTING AND FINANCING ACTIVITIES NOT INVOLVING CASH FLOWS:    
Right of use assets obtained in exchange for new operating lease liabilities 33
Issuance costs of ELOC agreement 750
Issuance costs of the Warrant inducement agreement and Warrant to underwriter 3,049 2,651
Warrant to lenders $ 22 $ 84